{"disease":{"id":"overweight-with-comorbidities","name":"overweight with comorbidities"},"drugs":{"marketed":[],"pipeline":[],"offLabel":[],"totalMarketed":0,"totalPipeline":0},"trials":{"data":[{"nct_id":"NCT07481747","title":"Efficacy and Safety of Tirzepatide Once Weekly Versus Placebo in Participants Who Are Either Obese or Overweight With Weight-Related Comorbidities (SURMOUNT-1)","phase":"PHASE3","overall_status":"RECRUITING","enrollment_count":2539,"lead_sponsor_name":"Hudson Biotech","has_results":false},{"nct_id":"NCT07255209","title":"A Study of IBI362 in Chinese Adolescents With Obesity or Overweight","phase":"PHASE3","overall_status":"RECRUITING","enrollment_count":180,"lead_sponsor_name":"Innovent Biologics (Suzhou) Co. Ltd.","has_results":false},{"nct_id":"NCT04167553","title":"Study for Multiple Doses of HM15136(Efpegerglucagon) in Obese or Overweight Subjects With Comorbidities","phase":"PHASE1","overall_status":"COMPLETED","enrollment_count":52,"lead_sponsor_name":"Hanmi Pharmaceutical Company Limited","has_results":true}],"total":3},"guidelines":[],"source":"Drug Landscape verified database"}